But it is useful for patients who present with obvious upper respiratory tract infections. If someone is clearly sick the test will work.
The availability of antibody tests such as this one enables other (direct virus) tests to be prioritised to specific patient cohorts .
The overall level of testing can therefore be increased because antibody tests are available.
Ann: Cellmid Signs COVID-19 Rapid Diagnostic Supply Agreement, page-145
-
- There are more pages in this discussion • 1,126 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AN1 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.690M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| AN1 (ASX) Chart |
Day chart unavailable